I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Clinically relevant glioblastoma patient-derived xenograft ..:
Joshua Alcaniz
;
Lars Winkler
;
Mathias Dahlmann
...
https://www.frontiersin.org/articles/10.3389/fonc.2023.1129627/full. , 2023
Link:
https://doi.org/10.3389/fonc.2023.1129627
RT Journal T1
Clinically relevant glioblastoma patient-derived xenograft models to guide drug development and identify molecular signatures
UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:162e4abdb64b415cb7d728a8287cc659&Exemplar=1&LAN=DE A1 Joshua Alcaniz A1 Lars Winkler A1 Mathias Dahlmann A1 Michael Becker A1 Andrea Orthmann A1 Johannes Haybaeck A1 Stefanie Krassnig A1 Christina Skofler A1 Tobias Kratzsch A1 Susanne A. Kuhn A1 Andreas Jödicke A1 Michael Linnebacher A1 Iduna Fichtner A1 Wolfgang Walther A1 Jens Hoffmann PB Frontiers Media S.A. YR 2023 K1 glioblastoma K1 glioma K1 patient-derived xenograft (PDX) K1 preclinical oncology K1 drug efficacy K1 targeted therapy K1 Neoplasms. Tumors. Oncology. Including cancer and carcinogens K1 RC254-282 JF https://www.frontiersin.org/articles/10.3389/fonc.2023.1129627/full LK http://dx.doi.org/https://doi.org/10.3389/fonc.2023.1129627 DO https://doi.org/10.3389/fonc.2023.1129627 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)